Poseida Therapeutics, Inc. financial data

Symbol
PSTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
9390 Towne Centre Drive, Suite 200, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 327 % -39.3%
Debt-to-equity 150 % +51.2%
Return On Equity -97.4 % -241%
Return On Assets -38.9 % -172%
Operating Margin -139 % -355%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.5M shares +11.5%
Common Stock, Shares, Outstanding 96.8M shares +11.6%
Entity Public Float 123M USD +22.9%
Common Stock, Value, Issued 10K USD +11.1%
Weighted Average Number of Shares Outstanding, Basic 96M shares +11.3%
Weighted Average Number of Shares Outstanding, Diluted 96M shares +11.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 82.5M USD -40.8%
Research and Development Expense 162M USD +13.8%
General and Administrative Expense 35.4M USD -11%
Operating Income (Loss) -115M USD -170%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -123M USD -94.3%
Income Tax Expense (Benefit) 107K USD -80.3%
Net Income (Loss) Attributable to Parent -109M USD -143%
Earnings Per Share, Basic -1.17 USD/shares -185%
Earnings Per Share, Diluted -1.17 USD/shares -185%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.3M USD +32.8%
Cash, Cash Equivalents, and Short-term Investments 199M USD -19.7%
Accounts Receivable, after Allowance for Credit Loss, Current 12M USD +42.6%
Assets, Current 217M USD -16.9%
Property, Plant and Equipment, Net 18.4M USD -17%
Operating Lease, Right-of-Use Asset 20.9M USD -13.9%
Intangible Assets, Net (Excluding Goodwill) 1.32M USD 0%
Goodwill 4.23M USD 0%
Other Assets, Noncurrent 1.08M USD +2.46%
Assets 263M USD -16.3%
Accounts Payable, Current 2.7M USD -15.5%
Employee-related Liabilities, Current 5.22M USD +2.41%
Liabilities, Current 84.8M USD +74.1%
Deferred Income Tax Liabilities, Net 55K USD 0%
Operating Lease, Liability, Noncurrent 19.9M USD -16.3%
Other Liabilities, Noncurrent 2.75M USD +22.7%
Liabilities 178M USD +14.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -47K USD -2450%
Retained Earnings (Accumulated Deficit) -619M USD -21.4%
Stockholders' Equity Attributable to Parent 84.6M USD -46.3%
Liabilities and Equity 263M USD -16.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.1M USD +60.2%
Net Cash Provided by (Used in) Financing Activities -43K USD -104%
Net Cash Provided by (Used in) Investing Activities 24M USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 96.8M shares +11.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.83M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.01M USD +10.1%
Deferred Tax Assets, Valuation Allowance 201M USD +24.2%
Deferred Tax Assets, Gross 210M USD +22.4%
Operating Lease, Liability 25.9M USD -12.5%
Payments to Acquire Property, Plant, and Equipment 130K USD -83.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -109M USD -143%
Lessee, Operating Lease, Liability, to be Paid 32.4M USD -15.7%
Property, Plant and Equipment, Gross 38.6M USD +4.49%
Operating Lease, Liability, Current 6M USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.11M USD -19.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.37M USD +3.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.54M USD -26.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.26M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 91.3M USD +2.22%
Current Income Tax Expense (Benefit) 107K USD -80.3%
Unrecognized Tax Benefits 15.3M USD +29.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.42M USD +3%
Operating Lease, Payments 1.5M USD -11.8%
Additional Paid in Capital 300K USD
Current State and Local Tax Expense (Benefit) 56K USD -36.4%
Current Federal Tax Expense (Benefit) 51K USD -88.8%
Share-based Payment Arrangement, Expense 21M USD -2.33%
Interest Expense 8.9M USD +21.5%